NEWS2与休克状态对疑似脓毒症患者抗生素紧迫性分层的比较:一项回顾性多中心队列研究
NEWS2+<7者未见关联。提示NEWS2可能比单纯休克评估更好地识别需紧急抗生素治疗的患者。
要点
- NEWS2+评分<7的患者中,抗生素延迟与死亡率无关联。
适用人群与场景
- 成人(年龄≥18岁)经急诊科入院、因疑似感染接受治疗的患者,疑似感染定义为急诊到达6小时内采集血培养并静脉给予抗生素。
- 排除标准包括:急诊到达6小时内转向姑息治疗或死亡、从急性护理医院转院、精神科或产科入院、到达12小时内生命体征或关键实验室检查缺失、到达前已口服或静脉使用抗生素、数据不足以计算NEWS2评分、到达2天内SARS-CoV-2 PCR阳性。
- 研究场景为9家医院急诊科,病情阶段为急诊初始评估与早期抗生素治疗阶段。
诊断标准与关键阈值
- 休克定义:持续低血压且乳酸>2 mmol/L。
- NEWS2+评分:按英国NICE指南计算,若患者存在中性粒细胞减少、乳酸浓度>2 mmol/L或到达3小时内实验室证据显示新发器官功能障碍,则向上调整一个风险类别。
- NEWS2+风险分层:0分、1-4分、5-6分、≥7分;最高风险组为聚合评分≥7分(NICE指南推荐1小时内抗生素)。
处置流程与药物剂量
- 原文未提及具体药物剂量、给药途径、频次或疗程。
- 基于休克状态策略:休克患者推荐1小时内抗生素,可能脓毒症无休克患者推荐3小时内抗生素(Surviving Sepsis Campaign指南)。
- 基于NEWS2+策略:NEWS2+≥7分(最高死亡风险组)推荐1小时内抗生素(英国NICE指南)。
红旗征与不能漏的情况
- 中性粒细胞减少、乳酸>2 mmol/L或到达3小时内实验室证据显示新发器官功能障碍:需将NEWS2评分向上调整一个风险类别。
研究设计与关键结果
- NEWS2+<7患者中抗生素延迟与死亡率无关联。
证据类型、等级与局限
- 证据类型:回顾性、多中心队列研究。
- 局限:回顾性设计;单医疗系统(Mass General Brigham)内9家医院;观察性研究不能确立因果关系;原文未提及证据等级或推荐强度。
对床旁实践的改变
- 对疑似脓毒症患者,NEWS2+≥7分(含无休克者)应视为抗生素紧迫性高危人群,不应仅凭休克状态判断是否需要1小时内抗生素。
- 无休克且NEWS2+<7分的患者中,抗生素延迟与死亡率无关联,可能不需要同等级别的紧急抗生素策略。
- NEWS2+评分需根据中性粒细胞减少、乳酸>2 mmol/L或到达3小时内新发器官功能障碍实验室证据向上调整一个风险类别。
- 研究为回顾性观察性设计, findings需前瞻性验证后方可作为决策阈值推广。
指南或共识出处
- Surviving Sepsis Campaign指南(原文引用,未提供具体版本年份)。
- 英国国家卫生与临床优化研究所(NICE)指南(原文引用,未提供具体版本年份)。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The Surviving Sepsis Campaign guidelines stratify antibiotic urgency in suspected sepsis by shock status, recommending treatment within 1 h for patients with shock and within 3 h for possible sepsis without shock. UK National Institute for Health and Care Excellence (NICE) guidelines use National Early Warning Score 2 (NEWS2) risk categories, with a window of 1 h for the group at highest risk of mortality (aggregate score ≥7). We aimed to compare these strategies for identifying patients in whom antibiotic delays are associated with mortality.
METHODS: We conducted a retrospective cohort study between May 31, 2015, and Feb 28, 2024, of adults (age ≥18 years) admitted via the emergency departments of nine hospitals within the Mass General Brigham health-care system (MA, USA) and treated for suspected infection, defined as blood culture sampling and intravenous antibiotic administration within 6 h of emergency department arrival. Exclusion criteria included transition to palliative care or death within 6 h of arrival to emergency department, transfer from acute care hospitals, psychiatric or obstetric admissions, missing vital signs or key laboratory test results within 12 h of arrival, oral or intravenous antibiotic receipt before arrival, insufficient data to calculate NEWS2 scores, and positive SARS-CoV-2 PCR test results within 2 days of arrival. We estimated hourly associations between time to antibiotic administration and hospital mortality using multivariable logistic regression with generalised estimating equations, stratified by shock (defined as persistent hypotension and lactate >2 mmol/L) and by laboratory-upgraded NEWS2 scores (NEWS2+), which were calculated per UK NICE guidance by shifting patients up one category if they had neutropenia, lactate concentration higher than 2 mmol/L, or laboratory evidence of new organ dysfunction within 3 h of arrival.
FINDINGS: 115 464 encounters with suspected infection were identified, of which 15 797 were ineligible based on exclusion criteria. The final analysis cohort included 71 593 patients who contributed 99 667 encounters (52 835 [53%] male, 46 828 [47%] female). 4867 (4·9%) encounters had shock. NEWS2+ scores were 0 in 9672 (9·7%) encounters, 1-4 in 37 310 (37·4%) encounters, 5-6 in 26 134 (26·2%) encounters, and ≥7 in 26 551 (26·6%) encounters. Each additional hour to antibiotic administration was associated with higher mortality in encounters with shock (adjusted odds ratio [OR] 1·15, 95% CI 1·07-1·25; 1·5% absolute increase per hour, 95% CI 0·5-2·4), but not in those without shock (1·03, 1·00-1·05). Delays were also associated with higher mortality in encounters with NEWS2+ ≥7 (1·07, 1·04-1·11; 0·5% absolute increase per hour, 95% CI 0·3-0·8), including 22 902 (86·3%) of 26 551 encounters without shock (1·05, 1·01-1·09; 0·4% absolute increase per hour, 95% CI 0·1-0·6%). No association was observed in encounters with NEWS2+ scores less than 7.
INTERPRETATION: The NICE-defined high-risk NEWS2 category (scores ≥7) identified patients in whom each additional hour to antibiotic administration was associated with increased mortality, including many without shock, whereas no association was observed for lower NEWS2 scores. These findings suggest that NEWS2 might better target urgent antibiotic therapy beyond shock-based assessment alone.
FUNDING: US Agency for Healthcare Research and Quality and US Centers for Disease Control and Prevention.
参考来源
- Rhee C, Singer M, Pak TR, et al. NEWS2 versus shock status to stratify antibiotic urgency in patients with suspected sepsis: a retrospective, multicentre cohort study. Lancet Respir Med. 2026. PMID: 42556377. doi:10.1016/S2213-2600(26)00187-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。